Jacobson Pharma Corporation Limited (HKG:2633)
Hong Kong
· Delayed Price · Currency is HKD 1.260
0.00 (0.00%)
At close: Mar 10, 2026
HKG:2633 Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | 1,533 | 1,577 | 1,468 | 1,268 | 1,596 | 1,446 | Upgrade
|
| Revenue Growth (YoY) | -1.88% | 7.43% | 15.79% | -20.55% | 10.35% | -7.99% | Upgrade
|
| Cost of Revenue | 854.18 | 883.96 | 847.32 | 728.68 | 975.02 | 884.83 | Upgrade
|
| Gross Profit | 679.27 | 692.94 | 620.48 | 538.92 | 620.52 | 561.08 | Upgrade
|
| Selling, General & Admin | 327.97 | 324.24 | 332.38 | 297.92 | 397.63 | 407.59 | Upgrade
|
| Other Operating Expenses | -62.98 | -64.17 | -23.31 | -28.27 | -25.58 | -10.83 | Upgrade
|
| Operating Expenses | 264.99 | 260.07 | 309.07 | 269.65 | 372.06 | 396.76 | Upgrade
|
| Operating Income | 414.28 | 432.87 | 311.4 | 269.27 | 248.47 | 164.33 | Upgrade
|
| Interest Expense | -33.76 | -41.37 | -78.71 | -61.41 | -25.69 | -30.14 | Upgrade
|
| Interest & Investment Income | 12.32 | 16.69 | 27.68 | 17.88 | 3.02 | 2.09 | Upgrade
|
| Earnings From Equity Investments | 3.33 | 0.4 | 0.17 | -1.63 | -3.77 | -5.53 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.52 | 0.3 | -0.1 | 0.36 | 0.05 | -1.58 | Upgrade
|
| EBT Excluding Unusual Items | 395.65 | 408.89 | 260.44 | 224.47 | 222.08 | 129.17 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.11 | -0.84 | 1.62 | - | 3.3 | 7.46 | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.75 | -4.1 | -0.05 | -3.42 | 0.25 | 1.07 | Upgrade
|
| Asset Writedown | -22.22 | -30.32 | -7.43 | - | 5.55 | 0.49 | Upgrade
|
| Other Unusual Items | - | - | - | 29.3 | 0.25 | 82.39 | Upgrade
|
| Pretax Income | 371.78 | 373.63 | 254.58 | 250.35 | 231.43 | 220.57 | Upgrade
|
| Income Tax Expense | 69.21 | 72.79 | 44.41 | 42.98 | 43.73 | 34.26 | Upgrade
|
| Earnings From Continuing Operations | 302.58 | 300.83 | 210.17 | 207.37 | 187.71 | 186.31 | Upgrade
|
| Earnings From Discontinued Operations | - | - | 80.61 | 75.84 | - | 0 | Upgrade
|
| Net Income to Company | 302.58 | 300.83 | 290.78 | 283.21 | 187.71 | 186.31 | Upgrade
|
| Minority Interest in Earnings | - | - | -23.81 | -32.17 | -10.04 | -12.6 | Upgrade
|
| Net Income | 302.58 | 300.83 | 266.97 | 251.04 | 177.67 | 173.71 | Upgrade
|
| Net Income to Common | 302.58 | 300.83 | 266.97 | 251.04 | 177.67 | 173.71 | Upgrade
|
| Net Income Growth | 19.49% | 12.68% | 6.34% | 41.30% | 2.28% | -19.44% | Upgrade
|
| Shares Outstanding (Basic) | 1,992 | 1,986 | 1,920 | 1,911 | 1,916 | 1,916 | Upgrade
|
| Shares Outstanding (Diluted) | 1,992 | 1,986 | 1,920 | 1,912 | 1,916 | 1,916 | Upgrade
|
| Shares Change (YoY) | 1.80% | 3.42% | 0.45% | -0.21% | -0.03% | -3.37% | Upgrade
|
| EPS (Basic) | 0.15 | 0.15 | 0.14 | 0.13 | 0.09 | 0.09 | Upgrade
|
| EPS (Diluted) | 0.15 | 0.15 | 0.14 | 0.13 | 0.09 | 0.09 | Upgrade
|
| EPS Growth | 17.41% | 8.96% | 5.89% | 41.57% | 2.30% | -16.63% | Upgrade
|
| Free Cash Flow | 235.19 | 278.39 | 354.85 | 567.09 | 343.08 | 345.9 | Upgrade
|
| Free Cash Flow Per Share | 0.12 | 0.14 | 0.18 | 0.30 | 0.18 | 0.18 | Upgrade
|
| Dividend Per Share | 0.098 | 0.090 | 0.055 | 0.052 | 0.039 | 0.023 | Upgrade
|
| Dividend Growth | 50.00% | 63.64% | 6.18% | 33.51% | 68.70% | -48.89% | Upgrade
|
| Gross Margin | 44.30% | 43.94% | 42.27% | 42.52% | 38.89% | 38.80% | Upgrade
|
| Operating Margin | 27.02% | 27.45% | 21.22% | 21.24% | 15.57% | 11.37% | Upgrade
|
| Profit Margin | 19.73% | 19.08% | 18.19% | 19.80% | 11.13% | 12.01% | Upgrade
|
| Free Cash Flow Margin | 15.34% | 17.66% | 24.18% | 44.74% | 21.50% | 23.92% | Upgrade
|
| EBITDA | 530.84 | 541.86 | 415.94 | 380.38 | 391.76 | 299.89 | Upgrade
|
| EBITDA Margin | 34.62% | 34.36% | 28.34% | 30.01% | 24.55% | 20.74% | Upgrade
|
| D&A For EBITDA | 116.56 | 108.99 | 104.53 | 111.12 | 143.29 | 135.57 | Upgrade
|
| EBIT | 414.28 | 432.87 | 311.4 | 269.27 | 248.47 | 164.33 | Upgrade
|
| EBIT Margin | 27.02% | 27.45% | 21.22% | 21.24% | 15.57% | 11.37% | Upgrade
|
| Effective Tax Rate | 18.62% | 19.48% | 17.45% | 17.17% | 18.89% | 15.53% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.